Awang A, Md Isa N, Yunus R, Azhar Shah S, Md Pauzi S H
Universiti Kebangsaan Malaysia Medical Centre, Faculty of Medicine, Department of Pathology, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000, Kuala Lumpur, Malaysia.
Malays J Pathol. 2019 Dec;41(3):253-257.
Gleason scoring (GS) categorised prostatic adenocarcinoma into five prognostic grade groups (PGGs); associated with different prognosis and treatment. This study aims to correlate between Gleason scores of needle biopsies with the corresponding total prostatectomy specimens, and to assess the relationship between the percentage of Gleason 4 tumour pattern (GP4) within Gleason score 7 (GS7) needle biopsy groups with the pathological staging.
Seventy-eight specimens of needle prostate biopsy and its subsequent radical prostatectomy were retrospectively studied. The GSs of the needle biopsy were compared with the corresponding prostatectomy specimens. The percentage of GP4 in GS7 needle biopsy groups was calculated and correlated with the pathological staging.
More than half (60%) of GS 6 needle biopsy cases (PGG 1) were upgraded in the prostatectomy specimen, while the majority (80%) of the GS7 needle biopsy groups (PGG 2 and 3) remain unchanged. Cohen's Kappa shows fair agreement in the Gleason scoring between needle biopsies and prostatectomy specimens, K = 0.324 (95% CI, 6.94 to 7.29), p <0.0005 and in the percentage of GP4 in GS7 needle biopsy groups and their corresponding radical prostatectomy specimens, K = 0.399 (95% CI 34.2 - 49.2), p<0.0005. A significant relationship was seen between the percentage of GP4 in GS7 needle biopsy with the pT and pN stage of its radical prostatectomy (p = 0.008 and p=0.001 respectively).
A higher percentage of GP4 in GS7 tumour is associated with worse tumour behaviour, therefore it is crucial for clinicians to realise this in deciding the optimal treatment.
Gleason评分(GS)将前列腺腺癌分为五个预后等级组(PGG);与不同的预后和治疗相关。本研究旨在将穿刺活检的Gleason评分与相应的前列腺根治性切除标本进行关联,并评估Gleason评分7(GS7)穿刺活检组中Gleason 4肿瘤模式(GP4)的百分比与病理分期之间的关系。
回顾性研究了78例前列腺穿刺活检标本及其随后的前列腺根治性切除标本。将穿刺活检的GS与相应的前列腺切除标本进行比较。计算GS7穿刺活检组中GP4的百分比,并将其与病理分期相关联。
超过一半(60%)的GS 6穿刺活检病例(PGG 1)在前列腺切除标本中被升级,而大多数(80%)的GS7穿刺活检组(PGG 2和3)保持不变。Cohen's Kappa显示穿刺活检与前列腺切除标本之间的Gleason评分具有中等一致性,K = 0.324(95% CI,6.94至7.29),p <0.0005;在GS7穿刺活检组及其相应的前列腺根治性切除标本中GP4的百分比方面,K = 0.399(95% CI 34.2 - 49.2),p<0.0005。GS7穿刺活检中GP4的百分比与其前列腺根治性切除的pT和pN分期之间存在显著关系(分别为p = 0.008和p = 0.001)。
GS7肿瘤中较高百分比的GP4与更差的肿瘤行为相关,因此临床医生在决定最佳治疗方案时认识到这一点至关重要。